×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Germany Biomarker Technologies Market

ID: MRFR/HC/54483-HCR
200 Pages
MRFR Team
June 2025

Germany Biomarker Technologies Market Research Report: By Product (Consumables, Instruments), By Profiling Technology (PCR, Imaging Technology, NGS), By Application (Cancer, Infectious Disease) andBy Research Area (Genomics, Proteomics)- Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Options

Germany Biomarker Technologies Market Summary

Industry Developments

The Germany Biomarker Technologies Market has recently experienced notable advancements, particularly with companies such as Roche and Thermo Fisher Scientific leading innovative developments in diagnostic and therapeutic biomarkers. In October 2023, Roche unveiled a new companion diagnostic test aimed at enhancing the precision of cancer treatments, reflecting the nation's focus on personalized medicine. Furthermore, partnerships between Agilent Technologies and local universities are fostering Research and Development initiatives, helping to accelerate biomarker discovery processes.In terms of mergers and acquisitions, in September 2023, Illumina announced the acquisition of a German biotechnology firm specializing in genomics, enhancing its product offerings and expanding its footprint within the European market. Likewise, Charles River Laboratories has strengthened its capabilities by partnering with a German laboratory service, focusing on biomarker validation and accelerating drug development timelines. Over the past few years, the market has seen continuous growth, with a significant valuation increase attributed to heightened research funding and a robust pipeline of diagnostic tests addressing critical health issues, particularly cancer and rare diseases. This evolving landscape reflects Germany's commitment to advancing biomarker technologies and improving healthcare outcomes.

Report Scope

Report Scope:
Report Attribute/Metric Source:Details
MARKET SIZE 20182.17(USD Billion)
MARKET SIZE 20242.85(USD Billion)
MARKET SIZE 20356.18(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 7.299% (2025 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
MARKET FORECAST PERIOD2025 - 2035
HISTORICAL DATA2019 - 2024
MARKET FORECAST UNITSUSD Billion
KEY COMPANIES PROFILEDCharles River Laboratories, Agilent Technologies, Merck Group, Abbott Laboratories, Roche, Thermo Fisher Scientific, PerkinElmer, QIAGEN, Genomic Health, BioMérieux, BioRad Laboratories, F. HoffmannLa Roche, Siemens Healthineers, Illumina
SEGMENTS COVEREDProduct, Profiling Technology, Application, Research Area
KEY MARKET OPPORTUNITIESPersonalized medicine advancements, Companion diagnostics growth, Adoption of liquid biopsies, Increased R&D funding, Rising demand for early diagnosis
KEY MARKET DYNAMICSIncreasing prevalence of diseases, Advancements in genomics technologies, Rise in personalized medicine trends, Growing demand for early diagnostics, Supportive government initiatives and funding
COUNTRIES COVEREDGermany

Leave a Comment

FAQs

What is the expected market size of the Germany Biomarker Technologies Market in 2024?

The Germany Biomarker Technologies Market is expected to be valued at 2.85 billion USD in 2024.

What will be the market size of the Germany Biomarker Technologies Market by 2035?

By 2035, the market size is projected to rise to 6.18 billion USD.

What is the compound annual growth rate (CAGR) for the Germany Biomarker Technologies Market between 2025 and 2035?

The CAGR for the market is expected to be 7.299 percent during the period from 2025 to 2035.

What are the primary product segments in the Germany Biomarker Technologies Market?

The primary product segments are Consumables and Instruments.

How much is the Consumables segment expected to be valued in 2035?

The Consumables segment is projected to be valued at 3.1 billion USD by 2035.

What is the expected value for the Instruments segment of the Germany Biomarker Technologies Market in 2024?

The Instruments segment is expected to be valued at 1.4 billion USD in 2024.

Who are the major players in the Germany Biomarker Technologies Market?

Major players include Charles River Laboratories, Agilent Technologies, Merck Group, Abbott Laboratories, and Roche.

What is the projected market value for the Instruments segment in 2035?

The Instruments segment is expected to reach a value of 3.08 billion USD by 2035.

What are the key applications driving growth in the Germany Biomarker Technologies Market?

Key applications include drug discovery, diagnostics, and personalized medicine.

Is there an impact of emerging technologies on the Germany Biomarker Technologies Market?

Yes, emerging technologies are creating significant opportunities and driving innovation within the market.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions